7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiomyopathies
The term cardiomyopathy refers to a variety of conditions in which the heart muscle becomes weakened or abnormally thickened, affecting its ability to pump blood effectively. Cardiomyopathies can be either inherited or acquired, with genetic mutations often playing a significant role in conditions like hypertrophic cardiomyopathy. As these diseases progress, they may lead to arrhythmias or heart failure, making early intervention crucial. Management strategies typically involve a combination of medications, lifestyle adjustments, and monitoring to prevent complications. In some cases, patients may require devices like pacemakers or even a heart transplant. With greater awareness and advancements in treatment, cardiomyopathies are becoming more manageable, offering hope for affected individuals.
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United StatesSubmit your abstract Today
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt